ro 48-8071 and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one

ro 48-8071 has been researched along with 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grinter, SZ; Huang, SY; Hyder, SM; Liang, Y; Zou, X1

Other Studies

1 other study(ies) available for ro 48-8071 and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one

ArticleYear
An inverse docking approach for identifying new potential anti-cancer targets.
    Journal of molecular graphics & modelling, 2011, Volume: 29, Issue:6

    Topics: Antineoplastic Agents; Aza Compounds; Benzophenones; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Computational Biology; DNA; Drug Discovery; Enzyme Inhibitors; Female; Humans; Intramolecular Transferases; Models, Molecular; Protein Binding; Protein Interaction Domains and Motifs; Tumor Suppressor Protein p53

2011